Recently, Furuya et al. reported that dysregulation of the mTOR pathway may induce cyst formation through proliferation of alveolar type II (ATII) cells [27], while Kumasaka et al. postulated that FLCN mutation may result in abnormalities at the alveolar-septal junction with few inflammatory changes [28]. The gene discussed is MTOR; the disease is cyst.